Unsere Publikationen

Adherence to Subcutaneous Interferon Beta-1a in Multiple Sclerosis Patients Receiving Periodic Feedback on Drug Use by Discussion of Readouts of Their Rebismart® Injector: Results of the Prospective Cohort Study REBIFLECT

Link
https://doi.org/10.1007/s12325-022-02100-w
Tags
Multiple SkleroseMS Behandlung
Jahr
2022
Autoren
Rieckmann P, Ziemssen T, Penner IK, Raji A, Wagner T, Richter J, Zettl UK.
Verlag
Adv Ther. 2022 Jun;39(6):2749-2760.
Zum Eintrag

Transparent Quality Optimization for Machine Learning-Based Regression in Neurology

Link
https://doi.org/10.3390/jpm12060908
Tags
Multiple SkleroseMobilitätManagement & Science
Jahr
2022
Autoren
Wendt K, Trentzsch K, Haase R, Weidemann ML, Weidemann R, Aßmann U, Ziemssen T.
Verlag
J Pers Med. 2022 May 31;12(6):908.
Zum Eintrag

FastCAT Accelerates Absolute Quantification of Proteins Using Multiple Short Nonpurified Chimeric Standards

Link
https://doi.org/10.1021/acs.jproteome.2c00014
Tags
Andere
Jahr
2022
Autoren
Rzagalinski I, Bogdanova A, Raghuraman BK, Geertsma ER, Hersemann L, Ziemssen T, Shevchenko A.
Verlag
J Proteome Res. 2022 Jun 3;21(6):1408-1417.
Zum Eintrag

OzEAN Study to Collect Real-World Evidence of Persistent Use, Effectiveness, and Safety of Ozanimod Over 5 Years in Patients With Relapsing-Remitting Multiple Sclerosis in Germany

Link
https://doi.org/10.3389/fneur.2022.913616
Tags
Multiple SkleroseMS BehandlungManagement & Science
Jahr
2022
Autoren
Ziemssen T, Richter S, Mäurer M, Buttmann M, Kreusel B, Poehler AM, Lampl M, Linker RA.
Verlag
Front Neurol. 2022 Jun 27;13:913616.
Zum Eintrag

Demographic Patterns of MS Patients Using BRISA: An MS-Specific App in Germany

Link
https://doi.org/10.3390/jpm12071100
Tags
Multiple SkleroseManagement & Science
Jahr
2022
Autoren
Balakrishnan P, Groenberg J, Jacyshyn-Owen E, Eberl M, Friedrich B, Joschko N, Ziemssen T.
Verlag
J Pers Med. 2022 Jul 1;12(7):1100.
Zum Eintrag

Timely intervention, monitoring and education MATTERS in MS (TIME MATTERS in MS): Development of a globally applicable quality improvement tool

Link
https://doi.org/10.1177/20552173221124023
Tags
Multiple Sklerose
Jahr
2022
Autoren
Hobart J, Butzkueven H, Haartsen J, Ziemssen T, Lane T, Giovannoni G.
Verlag
Mult Scler J Exp Transl Clin 2022;8(3).
Zum Eintrag

Case report: Variant-specific pre-exposure prophylaxis of SARS-CoV-2 infection in multiple sclerosis patients lacking vaccination responses

Link
https://doi.org/10.3389/fimmu.2022.897748
Tags
Multiple SkleroseNeuroimmunologie
Jahr
2022
Autoren
Woopen C, Konofalska U, Akgün K, Ziemssen T.
Verlag
Front Immunol 2022;13.
Zum Eintrag

Evaluation of the long-term clinical and economic impact of ofatumumab versus dimethyl fumarate and glatiramer acetate in patients with relapsing multiple sclerosis from a societal perspective in Germany

Link
https://doi.org/10.1177/20552173221085741
Tags
Multiple SkleroseMS Behandlung
Jahr
2022
Autoren
Koeditz D, Frensch J, Bierbaum M, Ness N-, Ettle B, Ziemssen T.
Verlag
Nervenheilkunde 2022;41(7-8):502-508.
Zum Eintrag
14 15 16 17 18

Publikationen durchsuchen

Publikationen filtern

Filters
Tags
Multiple Sklerose
MS Behandlung
Mobilität
Autonomes Nervensystem & Neuroendokrinologie
Neuroimmunologie
Herzratenvariabilität
Baroreflexsensitivität
Management & Science
eHealth
Gesundheitsökonomie
Andere
Show AllHide
Jahr
-